Our study demonstrated a causal association among pyruvate metabolism and the risk of BC, and found that ADH1B, ACSS2, ACACB, ADH1A, ALDH2, and ADH1C play a major part in the molecular mechanisms related to pyruvate metabolism in the occurrence of BC, and identified some potential targeted small molecule drugs. The gene discussed is ADH1A; the disease is breast cancer.